Andrew D. Dickinson - 10 Dec 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Chief Financial Officer
Signature: /s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson
Issuer symbol: GILD
Transactions as of: 10 Dec 2023
Net transactions value: -$94,350
Form type: 4
Filing time: 11 Dec 2023, 19:00:36 UTC
Previous filing: 13 Nov 2023
Next filing: 17 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+2,617	+2.5%		107,728	10 Dec 2023	Direct	F1
transaction	GILD	Common Stock	Tax liability	$94,350	-1,194	-1.1%	$79.02	106,534	10 Dec 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-2,617	-6.3%		38,834	10 Dec 2023	Common Stock	2,617		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.